問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberRSV MAT-008 (214753)
Completed

2022-02-15 - 2025-12-15

Phase III

Recruiting5

ICD-10B97.4

Respiratory syncytial virus as the cause of diseases classified elsewhere

ICD-9079.6

Respiratory syncytial virus(RSV) infections in conditions classified elsewhere and of unspecified site

  • Trial Applicant

    GlaxoSmithKline

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/08/01

Investigators and Locations

Principal Investigator Li-Min Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming Ho

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yao-Lung Chang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Sheng-Wen Shaw

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 黃建霈

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    4~20 participants

  • Global

    353 participants